Cardinal HealthRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Cardinal Health (CAH) reported revenue of $60.94B in Q1 2026, with Pharmaceutical Member its largest revenue segment at 92%.
Cardinal HealthThird of the big three US drug distributors, also a medical products manufacturer. GLP-1 sales rose significantly across fiscal 2024 and 2025 and lifted reported revenue, but the company disclosed that they did not meaningfully contribute to segment profit.
Q2 2024-Q1 2026
Q2 2024-Q1 2026
Q2 2024-Q1 2026
Cardinal Health (CAH) is a Medical - Distribution company. Third of the big three US drug distributors, also a medical products manufacturer. GLP-1 sales rose significantly across fiscal 2024 and 2025 and lifted reported revenue, but the company disclosed that they did not meaningfully contribute to segment profit. It was founded in 1971, is headquartered in Dublin, OH and employs about 57,700 people.
As of 2026-Q1, Cardinal Health's revenue breaks down across Pharmaceutical Member (92%), GMPD (5%), Other Operating (3%). See the revenue-by-segment chart for the full mix.
Track Cardinal Health's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated July 30, 2026.
Sterling groups Cardinal Health in the GLP-1 sector, alongside Hims & Hers Health (HIMS), McKesson (MCK), Cencora (COR) and CVS Health (CVS).
If you are researching Cardinal Health, also look at Hims & Hers Health (HIMS), McKesson (MCK) and Cencora (COR). You can compare all of them side by side or browse the full GLP-1 sector on Sterling.